Molecular Formula:C152H252N44O42
1
By reducing cortisol and indirectly supporting hormonal balance, DSIP promotes a favorable hormonal environment for muscle building and fat loss
7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks

Sc., Ph.D., FIDSA.,, DAYLAN PEREIRA, Pooja Bhartur, ACS Publications Society of Cosmetic Chemists HQ IFSCC Congress Cosmetic Ingredient Review CIRS Group American Academy of Dermatology British Association of Dermatologists PCPC, IADVL National Resident Commitee, Journal of Investigative Dermatology, Dermatology Times, European Academy of Dermatology and Venereology, Skin Health Alliance, The National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) #Dermatology #BlueLightProtection #Antioxidants #CosmeticScience #SkinHealth #Photoprotection #AntiAging #InnovationInDermatology #FutureOfSkincare #CosmeticResearch #SkinScience To view or add a comment, sign in Sun Protection, Evolved And We Helped Start It
Diabetes Care 39 , 231241 (2016)